GPT and erythema multiforme: TEAEs leading to treatment discontinuation in ≥ 2% of patients were increased ALT (10.0%), increased AST (8.3%), increased lipase (3.3%), drug eruption (3.3%), and erythema multiforme (3.3%) (Supplementary Table S5).